Enhancing "Patient-Reported Outcomes" through Wearable Technology and the Rise of "Home-Based" Clinical Assessments within the Duchenne Muscular Dystrophy Treatment Sector for 2026
In early 2026, the way we measure "Success" in Duchenne treatment is moving out of the hospital and into the home. Traditional tests like the "6-Minute Walk Test" (6MWT) are being supplemented—and in some cases replaced—by "Wearable Stride Monitors." These devices, worn on the ankle or wrist, provide a "Continuous Stream" of data on how a child moves in their natural environment...
0 Comments 0 Shares 230 Views 0 Reviews
Sponsored

Earn Money by Sharing! Simple • Fast • 100% Legit

Start making money online with just a single link. Share the link on WhatsApp, Instagram, Facebook, or anywhere — every click turns into real earnings. No investment, no skills required. Fast...